Measurements outcome

The most commonly discussed and most useful modes of economic evaluation are cost-benefit and cost-effectiveness analyses. These and other approaches share some common elements, in particular their conceptualization and measurement of costs, but differ in two main respects they measure outcomes differently, and consequently they address slightly different policy or practice questions. 

Mode of evaluation Cost measurement Outcome measurement... 

This example shows not only that it is difficult to develop outcome measures, but that measuring outcomes may be rendered more difficult and complicated by other factors. On the one hand, spurious effects may be found, caused by factors other than regulatory functions. On the other hand, even when regulation does work, detection of the desired outcomes and their impact may be difficult. 

Collaborative Working Group on Clinical Trial Evaluations. (1998). Measuring outcome in schizophrenia differences among the atypical antipsychotics. 

McGrath, R. G., MacMillan, I. C., Venkataraman, S. 1992. Measuring outcomes in corporate venturing an alternative perspective. Paper presented at the Academy of Management Best Paper Proceedings. 

A statistical measure of the frequency or regularity of occurrence of a measured outcome (or measurement) in an experiment subject to random fluctuations in the measurement. The fundamental axioms of mathematical probability are (a) if is any event in the sample space S, then the probabihty of E s occurrence [written P(E)] ranges over the interval from zero to one (b) over the entire sample space, F(E) equals one and (c) if events A and B are mutually exclusive, then the probability of their combined occurrence is the sum of the probabilities... 

Why is such a measurement difficult The probabilities to measure correspond to big deviations of the current from its average value, 11 — (J) (/, and are therefore exponentially small. For instance, in the shot noise regime PT(I) — exp (—(/)(/(//(A)jr/ej, Q I/(I)) 1 being the function to characterize. One has to concentrate on very rare measurement outcomes that occur with probability exp(—(/ r/e) 0. Such measurements can only be carried out with threshold detectors that discriminate these rare events. Let us discuss... 

Each of the preceding (i.e., structure, process, and outcomes) has been used to measure quality. Traditionally, quality in pharmacy practice has been measured by structure and process methods. This relies on a premise that a quality outcome is not possible without appropriate structure or process. Moreover, it is much simpler and less controversial to measure structure and process than it is to measure outcomes. Recently, however, outcomes quality measurement has become more prevalent. 

Measuring outcomes can seem to be a daunting task. This may have been why Anita s boss, pharmacist Pat (in the scenario), did not implement the corporate CQI program as recommended by his district manager. Thus the remainder of this chapter will present these concepts in an easy-to-understand manner and will include simple implementation tips. 

Provide a clear and concise road map for measurable outcomes... 

Explain how to test for a practically significant difference between two measured outcomes... 

Explain how to test for equivalence (i.e. show that two measured outcomes do not differ to an extent that is of practical significance)... 

Multiple regression allows the prediction of a measured outcome, using several predictors. A regression equation is developed containing a separate term for each predictor. These terms consists of a coefficient multiplied by the value of the particular predictor. 

Measurement Systems Analysis starts with translating customer and process requirements into metrics (measurable outcomes). These metrics can be based on subjective qualitative data (taste, appearance, etc.), or objective quantitative data (e.g., seconds, number of defects). The type of data determines the type of MSA ... 

The randomized controlled trial (RCT) is the de facto standard for studies of the health effects of medical interventions. In these studies, patients are randomized to receive either a therapy to be tested or an alternative (either a placebo or a conventional treatment), and an outcome is measured. RCTs have been used to evaluate therapeutic interventions, including drugs, radiation therapy, and surgical interventions, among others. The measured outcomes vary from hard evidence, such as mortality and morbidity, to softer evidence, such as patient-reported satisfaction and surrogate end points typified by markers of disease activity... 

There are two methodologies for assessing process performance in terms of a sigma metric (Figure 19-5). One approach is to measure outcomes by inspection. The other approach is to measure variation and predict process performance. For processes in which poor outcomes can be... 

Measure outcomes in the most appropriate and most disaggregate units. Categories can always be collapsed at a future time, but is impossible to split out variables beyond their original units. The sources of process and outcomes data may vary. 

Another issue is that when the measurement of efficacy is variable, it is impossible to determine what part of the measured outcome is due to the effect of the drug and what part is due to variability unrelated to the drug effect. The size of a drug effect is called the signal , whereas the variability associated with it is referred to as the noise . 

Identifying and measuring the outcomes of a pharmaceutical care adherence plan is also important. Objective measures of improved health status and/or reduced health care expenditures document success in a well-designed pharmaceutical care plan. Examples of measurable outcomes include a reduction in inappropriate use of the health care system (e.g., fewer emergency department visits for asthma exacerbations) or improved control of the patient s disease (e.g., HbAic levels below 1% in a patient with type 2 diabetes). 

Orthopedics has recognized the importance of measuring outcomes in terms of quality-adjusted life-years instead of length of implant survival.Similarly, pharmacy must implement software documentation solutions that facilitate outcomes monitoring beyond cost savings. Software is needed with the ability to calculate, in a cost-benefit analysis, the clinical impact of pharmacist interventions as they affect therapeutic, financial, and humanistic outcomes. The current array of products could be better integrated into documentation software to facilitate tabulation of these data. With the power of the Internet to manipulate data in a dynamic database, it would even be possible for hospitals to compare their outcomes on a local, regional, or national basis. Furthermore, the database could... 

Studies of informatics and clinical decision making concentrate on the benefits of using computerized decision support systems in clinical practice and in research to measure outcomes, efficiency, and effectiveness of care. Decision analysis in clinical research employs probability analysis to express uncertainty and utility theory to express patient preferences for health outcomes. 

Measuring outcomes shifts the emphasis from products to patient results, which could eliminate the need for formularies.Simply put, outcomes measurements evaluate systems and decide what works and what does not. 

Healthcare providers are increasingly relying on pharmacists to perform outcomes research and quality-of-life studies. Pharmacists can apply basic quantitative skills in evaluating options and combine the results with qualitative information to make decisions and recommendations. For disease state management programs, measuring outcomes can be the key to success. 

Disease-specific tools to measure outcomes Hypertension outcomes... 

Thus, the evolutions of the conditional reduced states Qu(t) decouple and they evolve independently. If, in particular, at least one measurement outcome is known, the corresponding reduced state has a probability one... 

---